In a major crackdown on pharmaceutical malpractice, Uttar Pradesh Police have registered cases against twelve medical store owners involved in a massive illegal cough syrup trade. The investigation has uncovered a sophisticated network that allegedly sold over 37 lakh bottles of codeine-based cough syrup using forged documents, with the estimated value of the illicit trade reaching approximately Rs 57 crore.
The Investigation That Uncovered the Scam
The case came to light following an extensive probe conducted by the state's drug department. Investigators discovered that more than a dozen medical stores across Uttar Pradesh had been systematically documenting the sale of codeine syrup through completely fabricated paperwork. The forged documents were created to show legitimate sales while the actual distribution happened through illegal channels.
Codeine syrup, a prescription medication containing an opioid substance, is strictly regulated under Indian drug laws due to its potential for abuse and addiction. The substance is particularly popular among drug abusers who consume it in large quantities to achieve a euphoric effect, leading to serious health consequences and dependency issues.
Massive Scale of Illegal Operations
The sheer volume of the illegal trade has shocked authorities. The 37 lakh bottles of codeine syrup represent one of the largest such cases uncovered in recent years. With each bottle having significant street value, the total worth of the illicit consignment reached the staggering figure of around Rs 57 crore.
What makes this case particularly concerning is the involvement of licensed medical store owners who are supposed to adhere to strict regulatory guidelines. Instead of following proper dispensing protocols, these establishments allegedly became key players in feeding the underground market for addictive substances.
Legal Actions and Ongoing Investigation
The UP Police have officially booked all twelve medical store owners under relevant sections of the Drug and Cosmetics Act and other applicable laws. The case was formally registered on November 23, 2025, marking the beginning of what promises to be a thorough legal process.
Authorities indicate that the investigation is continuing and may reveal more connections and participants in what appears to be a well-organized network. The drug department is working closely with police officials to trace the entire supply chain, from manufacturers to end consumers, and identify all individuals involved in facilitating this illegal trade.
This case highlights the ongoing challenge of regulating controlled substances in India's pharmaceutical sector. Despite strict laws and monitoring mechanisms, determined offenders continue to find ways to divert prescription medications to the black market, contributing to substance abuse problems across the country.
